Estimates of chronic hepatitis B virus infection in Australia, 2000

Abstract Objectives: To estimate the prevalence of chronic hepatitis B virus (HBV) infection in Australia and attributable proportions associated with specific demographic groups at higher risk of infection. Methods: Two methods were used to estimate prevalence of HBV surface antigen (HBsAg): (1) Po...

Full description

Bibliographic Details
Main Authors: Belinda G. O'Sullivan, Heather F. Gidding, Matthew Law, John M. Kaldor, Gwendolyn L. Gilbert, Gregory J. Dore
Format: Article
Language:English
Published: Wiley 2004-06-01
Series:Australian and New Zealand Journal of Public Health
Online Access:https://doi.org/10.1111/j.1467-842X.2004.tb00697.x
id doaj-115c0ed7d5f1439bab1fbc7d6e4f5d6b
record_format Article
spelling doaj-115c0ed7d5f1439bab1fbc7d6e4f5d6b2020-11-25T00:31:14ZengWileyAustralian and New Zealand Journal of Public Health1326-02001753-64052004-06-0128321221610.1111/j.1467-842X.2004.tb00697.xEstimates of chronic hepatitis B virus infection in Australia, 2000Belinda G. O'Sullivan0Heather F. Gidding1Matthew Law2John M. Kaldor3Gwendolyn L. Gilbert4Gregory J. Dore5New South Wales Public Health Officer Training Program, Department of Health, New South WalesNational Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and University of Sydney, New South WalesNational Centre in HIV Epidemiology and Clinical Research, University of New South WalesNational Centre in HIV Epidemiology and Clinical Research, University of New South WalesNational Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and University of Sydney, New South WalesNational Centre in HIV Epidemiology and Clinical Research, University of New South WalesAbstract Objectives: To estimate the prevalence of chronic hepatitis B virus (HBV) infection in Australia and attributable proportions associated with specific demographic groups at higher risk of infection. Methods: Two methods were used to estimate prevalence of HBV surface antigen (HBsAg): (1) Population‐based: results of a national serosurvey using sera collected opportunistically from laboratories across Australia were used for 1–59 year olds, with the HBsAg prevalence for 50–59 years extrapolated to the population aged 60 years and over; (2) Risk group‐based: estimates for selected high‐risk groups (injecting drug users, homosexual men, Indigenous Australians and people born in high‐prevalence countries), using source data from antenatal HBV screening in central Sydney, HBV prevalence studies, and estimates for low‐risk groups (first‐time blood donors) were combined proportionally to their representation in the population. Results: Prevalence of HBsAg in the national serosurvey increased, with age, from 0.0% for 1–4 and 5–9 year olds to 1.3–1.8% for the 40–49 year age group. Australian population HBsAg prevalence based on minimum and adjusted estimates from this serosurvey were 91,500 (0.49%) and 163,000 (0.87%) infections, respectively. The risk group method estimated an Australian HBsAg prevalence of 88,000 infections (0.47%). Approximately 50% of people with chronic HBV infection were estimated to be immigrants from either South‐East Asia (33.3%) or North‐East Asia (16.2%). Conclusion: The range of estimates for chronic HBV infection in Australia is broad, reflecting the uncertainty in source data. A national blood survey encompassing a large and representative population sample may help to provide more accurate estimates. A large proportion of people with chronic HBV infection are Asian born.https://doi.org/10.1111/j.1467-842X.2004.tb00697.x
collection DOAJ
language English
format Article
sources DOAJ
author Belinda G. O'Sullivan
Heather F. Gidding
Matthew Law
John M. Kaldor
Gwendolyn L. Gilbert
Gregory J. Dore
spellingShingle Belinda G. O'Sullivan
Heather F. Gidding
Matthew Law
John M. Kaldor
Gwendolyn L. Gilbert
Gregory J. Dore
Estimates of chronic hepatitis B virus infection in Australia, 2000
Australian and New Zealand Journal of Public Health
author_facet Belinda G. O'Sullivan
Heather F. Gidding
Matthew Law
John M. Kaldor
Gwendolyn L. Gilbert
Gregory J. Dore
author_sort Belinda G. O'Sullivan
title Estimates of chronic hepatitis B virus infection in Australia, 2000
title_short Estimates of chronic hepatitis B virus infection in Australia, 2000
title_full Estimates of chronic hepatitis B virus infection in Australia, 2000
title_fullStr Estimates of chronic hepatitis B virus infection in Australia, 2000
title_full_unstemmed Estimates of chronic hepatitis B virus infection in Australia, 2000
title_sort estimates of chronic hepatitis b virus infection in australia, 2000
publisher Wiley
series Australian and New Zealand Journal of Public Health
issn 1326-0200
1753-6405
publishDate 2004-06-01
description Abstract Objectives: To estimate the prevalence of chronic hepatitis B virus (HBV) infection in Australia and attributable proportions associated with specific demographic groups at higher risk of infection. Methods: Two methods were used to estimate prevalence of HBV surface antigen (HBsAg): (1) Population‐based: results of a national serosurvey using sera collected opportunistically from laboratories across Australia were used for 1–59 year olds, with the HBsAg prevalence for 50–59 years extrapolated to the population aged 60 years and over; (2) Risk group‐based: estimates for selected high‐risk groups (injecting drug users, homosexual men, Indigenous Australians and people born in high‐prevalence countries), using source data from antenatal HBV screening in central Sydney, HBV prevalence studies, and estimates for low‐risk groups (first‐time blood donors) were combined proportionally to their representation in the population. Results: Prevalence of HBsAg in the national serosurvey increased, with age, from 0.0% for 1–4 and 5–9 year olds to 1.3–1.8% for the 40–49 year age group. Australian population HBsAg prevalence based on minimum and adjusted estimates from this serosurvey were 91,500 (0.49%) and 163,000 (0.87%) infections, respectively. The risk group method estimated an Australian HBsAg prevalence of 88,000 infections (0.47%). Approximately 50% of people with chronic HBV infection were estimated to be immigrants from either South‐East Asia (33.3%) or North‐East Asia (16.2%). Conclusion: The range of estimates for chronic HBV infection in Australia is broad, reflecting the uncertainty in source data. A national blood survey encompassing a large and representative population sample may help to provide more accurate estimates. A large proportion of people with chronic HBV infection are Asian born.
url https://doi.org/10.1111/j.1467-842X.2004.tb00697.x
work_keys_str_mv AT belindagosullivan estimatesofchronichepatitisbvirusinfectioninaustralia2000
AT heatherfgidding estimatesofchronichepatitisbvirusinfectioninaustralia2000
AT matthewlaw estimatesofchronichepatitisbvirusinfectioninaustralia2000
AT johnmkaldor estimatesofchronichepatitisbvirusinfectioninaustralia2000
AT gwendolynlgilbert estimatesofchronichepatitisbvirusinfectioninaustralia2000
AT gregoryjdore estimatesofchronichepatitisbvirusinfectioninaustralia2000
_version_ 1725322931318292480